NHI Announces Third Quarter 2025 Results

About this update from National Health Investors, Inc.

[{"type":"text","content":"MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2025.","length":182,"tagName":"p"},{"type":"text","content":"CEO Comments","length":12,"tagName":"p"},{"type":"text","content":""NHI had another strong quarter highlighted by the transition of seven properties to our SHOP portfolio that resulted in consolidated SHOP NOI year-over-year growth of approximately 63%," said Eric Mendelsohn, NHI's President and CEO.","length":248,"tagName":"p"},{"type":"text","content":""We also announced our first SHOP acquisition for $74.3 million which, combined with the recent transitions, should more than double our SHOP NOI. We have taken measures to improve the performance of our Same Store SHOP portfolio, and we continue to expect significant organic upside from those properties with NOI growth returning to double-digit levels in 2026.","length":368,"tagName":"p"},{"type":"text","content":"Acquisitions continue to meaningfully contribute to our growth, and we have already surpassed last year's investment activity with $303.2 million announced to date and more expected before the end of the year. The pipeline is in great shape, setting up 2026 for another year of excellent external growth. We believe our strong balance sheet continues to provide NHI a strategic advantage with ample access to capital to fund this growth. We are pleased to increase our guidance for the third time this year and we believe that NHI is well-positioned for several years of excellent growth," concluded Mr. Mendelsohn.","length":624,"tagName":"p"},{"type":"text","content":"Financial Results and Recent Events","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders per diluted share for the three months ended September 30, 2025 was $0.69 per share compared to $0.65 per share during the same period in the prior year. Net income attributable to common stockholders per diluted share for the nine months ended September 30, 2025 was $2.22 per share compared to $2.17 per share during the same period in the prior year. Net income attributable to common stockholders for the nine months ended September 30, 2025 included $1.6 millionof proxy contest and ...

More updates from National Health Investors, Inc.